Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis
- PMID: 19574105
- DOI: 10.1016/j.spinee.2009.05.008
Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis
Abstract
Background context: Results recently reported in the literature have raised some concerns regarding the use of recombinant human bone morphogenetic protein (rhBMP-2) in the cervical spine.
Purpose: We undertook a radiological and clinical review of cervical fusions performed at our institution with polyetheretherketone (PEEK) interbody cage and rhBMP-2.
Study design: Observational study.
Patient sample: Perioperative clinical and radiologic data of all patients who underwent an anterior cervical discectomy and fusion using PEEK and rhBMP-2 for cervical spondylotic radiculopathy or myelopathy were collected.
Outcome measures: Images were examined for fusion, heterotopic ossification, end-plate resorption, subsidence, and segmental sagittal alignment.
Methods: All patients underwent detailed postoperative radiologic analysis using a computed tomography (CT) scan obtained at least 6 months postoperatively and plain X-rays obtained at regular intervals.
Results: Twenty-two patients had 38 levels fused using PEEK and varying doses of rhBMP-2. No anterior cervical swelling requiring additional procedures or longer than anticipated hospital stays occurred. Pseudoarthrosis, shown as a horizontal radiolucent fissure through the midportion of the PEEK cage on CT, occurred in four patients. Excessive bone growth into the spinal canal or foramina occurred in 26 (68%) patients but did not result in neurologic sequelae. Cystic regions in the core of the PEEK spacer were seen in most patients, with 15 levels (39%) having cysts measuring 3mm or greater. Moderate or severe osteolysis of the end plates occurred in 57% of levels, and this led to subsidence of the construct and loss of some of the segmental sagittal alignment (ie, lordosis) that had been achieved with surgery.
Conclusions: The unlimited supply of PEEK spacers and rhBMP-2 and their ease of use make them attractive platforms to achieve fusion. This study has demonstrated that the fusion process using rhBMP-2 is a dynamic one, with osteolysis dominating the initial phase, leading to end-plate resorption and consequently loss of some of the disc space height and sagittal alignment that was achieved with surgery. There is a high incidence of bone growth beyond the core of the PEEK spacer and cystic regions within the cage. Given our experience, we currently reserve the use of PEEK and rhBMP-2 for use in those patients who are at greatest risk of pseudoarthrosis.
Comment in
-
Aggressive end plate decortication as a cause of osteolysis after rhBMP-2 use in cervical spine interbody fusion.Spine J. 2010 Feb;10(2):187-8; author reply 188. doi: 10.1016/j.spinee.2009.10.001. Spine J. 2010. PMID: 20142074 No abstract available.
Similar articles
-
Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.J Spinal Disord Tech. 2008 Dec;21(8):557-62. doi: 10.1097/BSD.0b013e31815ea897. J Spinal Disord Tech. 2008. PMID: 19057248 Clinical Trial.
-
Analysis of prevertebral soft-tissue swelling and dysphagia in multilevel anterior cervical discectomy and fusion with recombinant human bone morphogenetic protein-2 in patients at risk for pseudarthrosis.J Neurosurg Spine. 2011 Feb;14(2):244-9. doi: 10.3171/2010.9.SPINE09828. Epub 2010 Dec 24. J Neurosurg Spine. 2011. PMID: 21184639
-
Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.Eur Spine J. 2007 Aug;16(8):1257-65. doi: 10.1007/s00586-007-0351-9. Epub 2007 Mar 27. Eur Spine J. 2007. PMID: 17387522 Free PMC article.
-
Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.Spine J. 2014 Mar 1;14(3):552-9. doi: 10.1016/j.spinee.2013.08.060. Epub 2014 Jan 8. Spine J. 2014. PMID: 24412416 Review.
-
Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma.Spine (Phila Pa 1976). 2008 Oct 1;33(21):2361-6. doi: 10.1097/BRS.0b013e318183971d. Spine (Phila Pa 1976). 2008. PMID: 18827703 Review.
Cited by
-
Polyetheretherketone (PEEK) for medical applications.J Mater Sci Mater Med. 2016 Jul;27(7):118. doi: 10.1007/s10856-016-5731-4. Epub 2016 Jun 3. J Mater Sci Mater Med. 2016. PMID: 27259708 Review.
-
Enhanced control of in vivo bone formation with surface functionalized alginate microbeads incorporating heparin and human bone morphogenetic protein-2.Tissue Eng Part A. 2013 Feb;19(3-4):350-9. doi: 10.1089/ten.TEA.2012.0274. Epub 2012 Nov 7. Tissue Eng Part A. 2013. PMID: 22894570 Free PMC article.
-
Salicylic Acid-Based Polymers for Guided Bone Regeneration Using Bone Morphogenetic Protein-2.Tissue Eng Part A. 2015 Jul;21(13-14):2013-24. doi: 10.1089/ten.TEA.2014.0455. Epub 2015 Apr 29. Tissue Eng Part A. 2015. PMID: 25813520 Free PMC article.
-
Exploratory meta-analysis on dose-related efficacy and complications of rhBMP-2 in anterior cervical discectomy and fusion: 1,539,021 cases from 2003 to 2017 studies.J Orthop Translat. 2020 Feb 18;24:166-174. doi: 10.1016/j.jot.2020.01.002. eCollection 2020 Sep. J Orthop Translat. 2020. PMID: 33101967 Free PMC article.
-
Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.Spine J. 2014 Sep 1;14(9):2051-9. doi: 10.1016/j.spinee.2013.11.042. Epub 2013 Dec 7. Spine J. 2014. PMID: 24321129 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical